title: Polymeric nanoparticles-based topical delivery systems for the treatment of dermatological diseases.
abstract: Human skin not only functions as a permeation barrier (mainly because of the stratum corneum layer) but also provides a unique delivery pathway for therapeutic and other active agents. These compounds penetrate via intercellular, intracellular, and transappendageal routes, resulting in topical delivery (into skin strata) and transdermal delivery (to subcutaneous tissues and into the systemic circulation). Passive and active permeation enhancement methods have been widely applied to increase the cutaneous penetration. The pathology, pathogenesis, and topical treatment approaches of dermatological diseases, such as psoriasis, contact dermatitis, and skin cancer, are then discussed. Recent literature has demonstrated that nanoparticles-based topical delivery systems can be successful in treating these skin conditions. The studies are reviewed starting with the nanoparticles based on natural polymers especially chitosan, followed by those made of synthetic, degradable (aliphatic polyesters), and nondegradable (polyacrylates) polymers; emphasis is given to nanospheres made of polymers derived from naturally occurring metabolites, the tyrosine-derived nanospheres (TyroSpheres™). In summary, the nanoparticles-based topical delivery systems combine the advantages of both the nanosized drug carriers and the topical approach, and are promising for the treatment of skin diseases. For the perspectives, the penetration of ultra-small nanoparticles (size smaller than 40 nm) into skin strata, the targeted delivery of the encapsulated drugs to hair follicle stem cells, and the combination of nanoparticles and microneedle array technologies for special applications such as vaccine delivery are discussed.
authors: The New Jersey Center for Biomaterials, Rutgers - The State University of New Jersey, Piscataway, NJ, USA.
authors: Zheng
authors: Z
authors: Zhang
authors: Pei-Chin
authors: PC
authors: Tsai
authors: Tannaz
authors: T
authors: Ramezanli
authors: Bozena B
authors: BB
authors: Michniak-Kohn
mesh_terms: D000287:Administration, Topical; D000818:Animals; D016503:Drug Delivery Systems; D006801:Humans; D053758:Nanoparticles / Q000737:chemistry*; D011108:Polymers / Q000737:chemistry*; D012867:Skin / Q000473:pathology; D012871:Skin Diseases / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology
chemical_list: D011108:Polymers
references: Nat Biotechnol. 2010 Dec;28(12):1300-3
references: 21057497
references: Eur J Pharm Biopharm. 2008 Mar;68(3):724-34
references: 17618097
references: Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19268-73
references: 19901335
references: J Control Release. 2012 Oct 10;163(1):18-24
references: 22732474
references: Physiol Rev. 1971 Oct;51(4):702-47
references: 4940637
references: Int J Dermatol. 2010 Sep;49(9):978-86
references: 20883261
references: Eur J Pharm Sci. 2012 Feb 14;45(3):320-9
references: 22155544
references: Adv Drug Deliv Rev. 2003 Feb 24;55(3):329-47
references: 12628320
references: J Pharm Pharmacol. 2009 Dec;61(12):1609-16
references: 19958582
references: Int J Pharm. 2006 Aug 17;319(1-2):130-8
references: 16713152
references: J Control Release. 2010 Mar 19;142(3):368-73
references: 19932722
references: Pharm Res. 2011 Jan;28(1):107-16
references: 20354765
references: J Control Release. 2004 Sep 14;99(1):53-62
references: 15342180
references: Vet Pathol. 2008 Jul;45(4):563-75
references: 18587106
references: Drug Deliv. 2011 Apr;18(3):215-22
references: 21226549
references: Bioorg Med Chem Lett. 2007 Sep 1;17(17):4771-7
references: 17658251
references: Biomacromolecules. 2007 Mar;8(3):998-1003
references: 17274654
references: Pharm Res. 2009 Aug;26(8):1974-85
references: 19499313
references: J Korean Med Sci. 1995 Apr;10(2):85-92
references: 7576299
references: J Control Release. 2010 Nov 1;147(3):326-32
references: 20692307
references: J Invest Dermatol. 2006 Jul;126(7):1459-68
references: 16778814
references: Eur J Pharm Biopharm. 2001 Sep;52(2):103-12
references: 11522474
references: Pharm Dev Technol. 2013 May-Jun;18(3):591-9
references: 22149945
references: Proc Natl Acad Sci U S A. 2012 Jul 24;109(30):11975-80
references: 22773805
references: Curr Drug Targets Inflamm Allergy. 2004 Jun;3(2):145-56
references: 15180467
references: Curr Drug Deliv. 2006 Jan;3(1):65-75
references: 16472095
references: Eur J Dermatol. 2009 Jul-Aug;19(4):325-32
references: 19447733
references: Nat Rev Immunol. 2005 Sep;5(9):699-711
references: 16138103
references: Am J Clin Dermatol. 2004;5(6):453-8
references: 15663342
references: Eur J Pharm Biopharm. 2004 Mar;57(2):251-61
references: 15018982
references: Cancer Res. 1986 Dec;46(12 Pt 1):6387-92
references: 2946403
references: Environ Mol Mutagen. 2006 Aug;47(7):509-17
references: 16673411
references: Int J Nanomedicine. 2011;6:1621-30
references: 21904452
references: Pharm Res. 2011 Jan;28(1):7-21
references: 20300802
references: Cancer Res. 1995 Aug 15;55(16):3604-9
references: 7627969
references: Drug Deliv. 2006 Sep-Oct;13(5):323-30
references: 16877306
references: Contact Dermatitis. 1987 Feb;16(2):55-78
references: 3552400
references: J Control Release. 2011 Jan 20;149(2):159-67
references: 20950659
references: Eur J Pharm Biopharm. 2001 Sep;52(2):191-5
references: 11522485
references: J Control Release. 2004 Jul 7;97(3):477-84
references: 15212879
references: Oligonucleotides. 2010 Jun;20(3):147-53
references: 20180684
references: Nat Rev Cancer. 2003 May;3(5):330-8
references: 12724731
references: Ther Deliv. 2010 Jul;1(1):109-31
references: 21132122
references: Mol Pharm. 2009 Sep-Oct;6(5):1441-8
references: 19630400
references: Nanomedicine. 2009 Mar;5(1):46-54
references: 18824416
references: Br J Dermatol. 2005 Apr;152(4):597-615
references: 15840088
references: J Clin Invest. 2006 Aug;116(8):2084-7
references: 16886055
references: Bioorg Med Chem Lett. 2007 Jan 1;17(1):53-6
references: 17049850
references: Int J Pharm. 2010 Dec 15;402(1-2):205-12
references: 20932886
references: Int J Pharm. 2008 Feb 28;350(1-2):312-9
references: 17897801
references: J Pharm Sci. 2003 Jun;92(6):1138-46
references: 12761803
references: Pharm Res. 2004 Oct;21(10):1818-25
references: 15553228
references: Int J Pharm. 2012 May 30;428(1-2):164-70
references: 22421322
references: Ann Surg. 2000 May;231(5):664-71
references: 10767787
references: Int J Pharm. 2009 Jan 21;366(1-2):190-200
references: 18812218
references: J Control Release. 2004 Jul 7;97(3):503-11
references: 15212882
references: Biomaterials. 2012 Feb;33(5):1607-17
references: 22118820
references: mBio. 2012 Mar 06;3(2):e00012-12
references: 22396479
references: Ann Surg. 1971 Jun;173(6):864-71
references: 5578800
references: Gene Ther. 2008 May;15(9):668-76
references: 18305575
references: Drug Target Insights. 2007;2:147-57
references: 21901071
references: Colloids Surf B Biointerfaces. 2011 Dec 1;88(2):706-10
references: 21885261
references: J Control Release. 2003 Jun 24;90(2):171-9
references: 12810300